广和通 reported revenue of ¥3.78B for the period ended 2026-06-30, +1.9% year on year. Net income was ¥0.07B, a 1.9% net margin on a 15.1% gross margin. The largest revenue line is 无线通信模组 at 92% of the total. Free cash flow for the period was ¥-0.73B.
| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥3.78B | +1.9% |
| Gross profit | ¥0.57B | — |
| Operating income | ¥0.08B | — |
| Net income | ¥0.07B | -66.7% |
| Gross margin | 15.1% | Net margin 1.9% |
| Revenue Q/Q | +25.1% | — |
| Segment | Revenue | Share |
|---|---|---|
| 无线通信模组 | ¥3.47B | 91.8% |
| 其他主营业务 | ¥0.27B | 7.0% |
| 其他(补充) | ¥0.04B | 1.2% |
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥3.21B | 84.9% |
| R&D | ¥0.29B | 7.6% |
| SG&A | ¥0.17B | 4.5% |
| Tax & other | ¥0.00B | 0.1% |
| Item | Amount |
|---|---|
| Total assets | ¥10.65B |
| Total liabilities | ¥4.56B |
| Shareholders' equity | ¥6.09B |
| Equity / assets | 57.2% |
| Operating cash flow | ¥-0.66B |
| Capital expenditure | ¥0.07B |
| Free cash flow | ¥-0.73B |
| Cash conversion (OCF / net income) | -2340% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
凯普生物 ・ 德艺文创 ・ 正丹股份 ・ 透景生命 ・ 万通智控 ・ 南京聚隆 ・ 正元智慧 ・ 超频三 ・ 星云股份 ・ 杭州园林 ・ 太龙股份 ・ 金陵体育
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies